Stephan Menzel

Dr. Stephan Menzel


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 1996 in Nature
Verified
Journal Article
Open access
PDF file
KYKazuya Yamagata
Kazuya Yamagata
HFHiroto Furuta
Hiroto Furuta
NONaohisa Oda
Naohisa Oda
PKPamela J. Kaisaki
Pamela J. Kaisaki
SMStephan Menzel
Stephan Menzel
GBGraeme I. Bell
Graeme I. Bell
THE disease maturity-onset diabetes of the young (MODY) is a genetically heterogeneous monogenic form of non-insulin-dependent (type 2) diabetes mellitus (NIDDM), characterized by early onset, usually before 25 years of age and often in adolescence or childhood, and by autosomal dominant inheritance1. It has been estimated that 2–5% of patients with NIDDM may have this form of diabetes mellitus2,3. Clinical studies have shown that predia-betic MODY subjects have normal insulin sensitivity but suffer from a defect in glucose-stimulated insulin secretion, suggesting that pancreatic β-cell dysfunction rather than insulin resistance is the primary defect in this disorder4,5. Linkage studies have localized the genes that are mutated in MODY on human chromosomes 20 (MODY1)6, 7 (MODY2)2 and 12 (MODY3}7, with MODY2 and MODY3 being allelic with the genes encoding glucokinase2, a key regulator of insulin secretion, and hepatocyte nuclear factor-1α (HNF-1α)8, a transcription factor involved in tissue-specific regulation of liver genes but also expressed in pancreatic islets, insulinoma cells and other tissues. Here we show that MODY1 is the gene encoding HNF-4α (gene symbol, TCP14), a member of the steroid/thyroid hormone receptor superfamily and an upstream regulator of HNF-1α expression9–11.

5 December 1996 in Nature
Verified
Journal Article
Closed access
PDF file
KYKazuya Yamagata
Kazuya Yamagata
NONaohisa Oda
Naohisa Oda
PKPamela J. Kaisaki
Pamela J. Kaisaki
SMStephan Menzel
Stephan Menzel
HFHiroto Furuta
Hiroto Furuta
GBGraeme I. Bell
Graeme I. Bell

2 September 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SMStephan Menzel
Stephan Menzel
CGChad Garner
Chad Garner
IGIvo Gut
Ivo Gut
FMFumihiko Matsuda
Fumihiko Matsuda
MYMasao Yamaguchi
Masao Yamaguchi
STSwee Lay Thein
Swee Lay Thein

11 October 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NSNicole Soranzo
Nicole Soranzo
TSTim D Spector
Tim D Spector
MMMassimo Mangino
Massimo Mangino
BKBrigitte Kühnel
Brigitte Kühnel
ARAugusto Rendon
Augusto Rendon
CGChristian Gieger
Christian Gieger

1 June 1996 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CHC.L. Hanis
C.L. Hanis
EBE. Boerwinkle
E. Boerwinkle
RCR. Chakraborty
R. Chakraborty
DED.L. Ellsworth
D.L. Ellsworth
PCPatrick Concannon
Patrick Concannon
GBG.I. Bell
G.I. Bell

3 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
STSwee Lay Thein
Swee Lay Thein
SMStephan Menzel
Stephan Menzel
XPXu Peng
Xu Peng
SBSteve Best
Steve Best
JJJie Jiang
Jie Jiang
MLMark Lathrop
Mark Lathrop
Individual variation in fetal hemoglobin (HbF, α 2 γ 2 ) response underlies the remarkable diversity in phenotypic severity of sickle cell disease and β thalassemia. HbF levels and HbF-associated quantitative traits (e.g., F cell levels) are highly heritable. We have previously mapped a major quantitative trait locus (QTL) controlling F cell levels in an extended Asian-Indian kindred with β thalassemia to a 1.5-Mb interval on chromosome 6q23, but the causative gene(s) are not known. The QTL encompasses several genes including HBS1L , a member of the GTP-binding protein family that is expressed in erythroid progenitor cells. In this high-resolution association study, we have identified multiple genetic variants within and 5′ to HBS1L at 6q23 that are strongly associated with F cell levels in families of Northern European ancestry ( P = 10 −75 ). The region accounts for 17.6% of the F cell variance in northern Europeans. Although mRNA levels of HBS1L and MYB in erythroid precursors grown in vitro are positively correlated, only HBS1L expression correlates with high F cell alleles. The results support a key role for the HBS1L -related genetic variants in HbF control and illustrate the biological complexity of the mechanism of 6q QTL as a modifier of fetal hemoglobin levels in the β hemoglobinopathies.